Deep learningâ€“based COVID-19 pneumonia classification
using chest CT images: model generalizability
Dan Nguyen1,2,a, Fernando Kay3, Jun Tan2, Yulong Yan2, Yee Seng Ng3, Puneeth Iyengar2,
Ron Peshock3, Steve Jiang1,2,a
1Medical

Artificial Intelligence and Automation (MAIA) Laboratory, University of Texas
Southwestern Medical Center, Dallas, TX, USA
2Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas,
TX, USA
3Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA
aCo-correspondence authors: {Dan.Nguyen, Steve.Jiang}@UTSouthwestern.edu

Abstract
Background: Since the outbreak of the COVID-19 pandemic, research efforts around the world
have begun to focus on the identification or categorization of COVID-19 positive patients using
artificial intelligence (AI) technologies on various medical data. Some developed AI models have
shown very high accuracy for diagnosis and prognosis of COVID-19 positive patients. However,
concerns have been raised over the generalizability of these models, given the heterogeneous
factors in training datasets such as patient demographics and pre-existing clinical conditions. The
goal of this study is to examine the severity of this problem by evaluating the generalizability of
deep learning (DL) classification models trained to identify COVID-19â€“positive patients on 3D
computed tomography (CT) datasets from different countries.
Methods: We collected one internal dataset at UT Southwestern (UTSW) (337 patients), and
three external datasets from three different countries: 1) CC-CCII Dataset (China), 2) COVIDCTset (Iran), and 3) MosMedData (Russia). We divided all the data into 2 classes: 1) COVID-19â€“
positive and 2) COVID-19â€“negative patients. The total number of patients/scans we used for each
data set was 101/101 (UTSW), 929/1544 (CC-CCII), 95/281 (COVID-CTset), and 856/856
(MOSMedData) for the positive labels, and 236/236 (UTSW), 1813/2634 (CC-CCII), 282/1068
(COVID-CTset), and 0/0 (MOSMedData) for the negative labels. We randomly divided the data,
by patients, into 72% training, 8% validation, and 20% testing. We trained nine identical DL-based
classification models by using various combinations of the datasets: 1) UTSW, 2) CC-CCII, 3)
COVID-CTset, 4) UTSW + CC-CCII, 5) UTSW + COVID-CTset, 6) CC-CCII + COVID-CTset, 7)
UTSW + CC-CCII + COVID-CTset, 8) CC-CCII + COVID-CTset + MosMedData, 9) UTSW + CCCCII + COVID-CTset + MosMedData.
Results: The models trained on a single dataset achieved accuracy/area under the receiver
operating characteristics curve (AUC) values of 0.87/0.826 (UTSW), 0.97/0.988 (CC-CCCI), and
0.86/0.873 (COVID-CTset) when evaluated on their own dataset. The models trained on multiple
datasets and evaluated on a test set from one of the datasets used for training performed better.
However, the performance dropped close to an AUC of 0.5 for all models when evaluated on a
different dataset. For example, the model trained on the UTSW and COVID-CTset together
achieved accuracies/AUCs to 0.91/0.937 and 0.94/0.926 when evaluated on the UTSW and
COVID-CT-set datasets, respectively, but evaluating the model on the CC-CCII dataset yielded
accuracy/AUC values of only 0.57/0.475. Including the MosMedData, which only contained
positive labels, into the training did not necessarily help the performance on the other datasets.

Conclusion: The models could identify COVID-19â€“positive patients if the testing data were in the
same dataset as the training data, and they performed better when trained on multiple datasets.
However, we observed poor performance, close to random guessing, when evaluating the model
on a dataset that it had never seen. Multiple factors likely contribute to these results, including but
not limited to patient demographics, pre-existing clinical conditions, and differences in image
acquisition or reconstruction, causing a data shift among different study cohorts.

I. Introduction
Since the outbreak of the 2019 coronavirus disease (COVID-19) in December 2019, the total
worldwide death count due to COVID-19 has exceeded a million deaths1. While COVID-19 can
affect many organ systems and cause fever, flu-like symptoms, cardiovascular damage, and
pulmonary injury. Since many of those who contract COVID-19 develop pneumonia, the most
common presentation of COVID-19 is pneumonia. While some patients are asymptomatic or have
mild symptoms, a small percentage of patients may develop severe acute respiratory distress
syndrome (ARDS) that requires intubation in intensive care and is associated with poor prognosis.
There is over 60% mortality once they progressed to a severe illness stage2. Since many chest
CTs are performed for reasons other than pulmonary symptoms, an automated tool that can
opportunistically screen chest CTs for the disease can potentially be used to identify patients with
COVID-19. Firstly, it has been suggested that patients with COVID-19 when identified early
stages can be treated to prevent progression to the later stage of the disease3-5. Secondly,
identification of asymptomatic patients in early stages provide a time window when they can
isolate themselves to prevent the spread to others.
Several efforts around the world have focused on the identification or categorization of COVID19â€“positive patients according to their various types of medical data. As part of the effort to
understand and control this disease, large COVID-19 datasets of different formats have been
curated and publicly released around the world. One group of studies focuses on using artificial
intelligence (AI) technologies, in particular deep learning (DL)â€“based models, to detect COVID19 from chest radiography and computed tomography (CT). These studies found high accuracy
rates ranging from 82% to 98%6-16. The high accuracy rates are promising and encourage the use
of this technology in the clinical setting.
However, the generalizability of these models to other clinical settings around the world is not
clear. The data usually found in clinical practice are often incomplete and noisy, and there may
have high intra- and inter-study variability among different environments. This scenario often
makes it difficulty from a research perspective to develop for algorithms and implement them in
the clinic. Due to many restrictions on sharing patient data, many algorithms are developed with
limited data that are specific to a clinic or a region. However, differences in several demographic
factors, such as a populations distribution of race, ethnicity, and geography, can greatly impact
the overall accuracy and performance of an algorithm in a different clinical setting17. In addition,
different methods of data collection by hospitals around the world may also impact an algorithmâ€™s
performance. Because the boom of AI technologies has only happened within the last several
years, the number of studies testing the robustness and performance of AI algorithms across
various clinical settings is extremely limited17. Therefore, there is very little knowledge about how
well a model will perform in a realistic clinical environment over time.

For example, Barish et al.18 demonstrated that a particular public model developed by Yan et al.19
that predicted mortality from COVID-19â€“positive patientsâ€”which performed well on an internal
dataset with an accuracy 0.878â€”failed to accurately predict mortality on an external dataset, with
an accuracy of only around 0.5. Another similar negative study applied Yan et al.â€™s model on an
external dataset and drew similar conclusions about the accuracy of its mortality prediction20. A
systematic review of 107 studies with 145 prediction models was conducted, and they found that
all models had high bias, due to non-representative control dataset and overly optimistic reported
performance21, which can additionally lead to unrealistic expectations among clinicians, policy
makers, and patients22. An article by Bachtiger et al. had concluded that this boom of AI models
for covid-19 focused far too much on developing novel prediction models without a
comprehensive understanding of its practical application and biases from the dataset23. Others
have similarly concluded that AI has yet to have any impact on the pandemic at hand, and that
extensive and comprehensive gathering of diagnostic COVID-19â€“related data will be essential do
develop useful AI models24.
As part of the efforts to collect data, large datasets of 3D computed tomography (CT) scans with
COVID-19â€“related labels have been publicly released. This provides us with an opportunity to
study the generalizability of DL algorithms developed using these volumetric datasets. In this
study, we collected and studied one internal dataset collected at UT Southwestern and three large
external datasets from around the world: 1) China Consortium of Chest CT Image Investigation
(CC-CCII) Dataset (China)25, 2) COVID-CTset (Iran)26, and 3) MosMedData (Russia)27. We
trained a DL-based classification model on various combinations of the datasets and evaluated
the model performance on held-out test data from each of the datasets.

II. Methods
II.1. Data
We collected one internal dataset at UT Southwestern (UTSW) and three large datasets from
around the world that are publicly availableâ€”1) China Consortium of Chest CT Image
Investigation (CC-CCII) Dataset (China), 2) COVID-CTset (Iran), and 3) MosMedDat (Rusia)â€”
which is summarized in Table 1. The UTSW dataset is composed of three subsets of anonymized
imaging data obtained retrospectively. The study protocol was approved by the institutional review
board and the requirement for informed consent was waived. The first subset includes patients
who tested positive for Severe Acute Respiratory Syndrome Coronavirus-2 on real-time
polymerase chain reaction between March and November 2020 and who had a chest CT scan
performed within the first seven days of the diagnosis. All chest CT scans were obtained according
to standard clinical care â€“ common clinical indications were to assess worsening respiratory
status and to rule out pulmonary thromboembolism. Chest CT is not obtained as a first line
modality to diagnose or screen for COVID-19 at UTSW. The second and third subsets include
patients who had a chest CT scan obtained as part of standard clinical care between March and
May 2019, i.e., pre-COVID-19 pandemic phase. The radiologic reports of these studies were
screened by a cardiothoracic radiologist with 12 year of clinical experience. The reports were
labeled as having radiologic findings suggestive of infection or not. The adjudication was based
on the presence of radiologic patterns usually associated with infection, including ground-glass
opacities, consolidation, and nodular pattern, if such findings were described as fitting a
differential diagnosis of infectious process based on the impression by the primary interpreting
radiologists. These studies were consecutively selected to match the sex and age distribution of
the COVID-19 positive subset and to represent two control groups with a balanced representation
of chest CT showing findings suggestive of infection (118) and findings not related to infection

(118).The CC-CCII dataset was obtained from six different hospitals: 1) Sun Yat-sen Memorial
Hospital and Third Affiliated Hospital of Sun Yat-sen University, 2) The first Affiliated Hospital of
Anhui Medical University, 3) West China Hospital, 4) Nanjing Renmin Hospital, 5) Yichang Central
Peopleâ€™s Hospital, 6) Renmin Hospital of Wuhan University. The COVID-CTset dataset was from
the Negin Medical Center, and the MOSMedData dataset was from municipal hospitals in Moscow,
Russia.
For consistency in training and testing the models in our study, we divided all the data into two
classes: 1) COVID-19â€“positive and 2) COVID-19â€“negative patients. Note that the MosMedData
does not have conclusive negativeâ€“label patients, as CT-0 might contain both positive and
negative patients. Accordingly, we omitted the CT-0 category from this study. Most scans in this
study had a matrix size of 512 x 512 x n, where n was a variable number of slices. The small
number of scans that had a reduced matrix size, images were linearly interpolated to match the
512 x 512 x n resolution.
Some data were available in Hounsfield Units (HU), while other data were available in relative
intensity values (e.g., 0 to 255). Because the data formatting varied across datasets, we
performed clipping and normalization operations. First, if the data were displayed in HU, we
clipped the minimum number to be -1000 HU. For evaluation, the data were normalized from 0 to
1 prior to evaluation by the DL model. For training, multiple normalization methods were used as
part of a data augmentation technique. The complete data augmentation is further described in
section in Section II.3. Figure 1 shows example CTs of COVID-19 positive patients from each
dataset.

Figure 1: Slice view of example CTs from each dataset. Red arrows show patchy groundglass opacities with round morphology, which are typical findings in COVID-19 pneumonia.
For training, validating, and testing the model, the positive labels of the UTSW dataset was
randomly split into 73 train, 8 validation, and 20 test patients and scans (one 3D scan per patient).
The positive labels of the CC-CCII dataset were randomly split into 669 train, 74 validation, and
186 test patients, or 1110 train,122 validation, 312 test scans. The positive labels of the COVIDCTset were randomly split into 68 train, 8 validation, and 19 test patients, or 201 train, 23
validation, and 57 test patients. The positive labels of the MosMedData were randomly split into
616 train, 69 validation, and 171 test patients and scans (one 3D scan per patient. CT-0 category
was omitted).
For the negative labels, the UTSW dataset was randomly split into 170 training, 18 validation, and
48 testing patients and scans (one 3D scan per patient). The CC-CCII dataset was randomly split
1305 train,145 validation, and 363 test patients, or 1891 train, 203 validation, and 540 test scans.

The COVID-CTset was randomly split into 259 train, 29 validation, and 72 test patients, or 770
train, 84 validation, and 214 test scans.
Table 1: Summary of data used in the study. These datasets include full volumetric CT
scans of the patients
Description
Available
Dataset
Origin
#
# 3D
at:
label
patients scans
COVID-19
101
101
positive
Infection
118
118
o UT Southwestern Medical
(negative)
*See
UTSW
footnote 1
Center
Findings
Unrelated
118
118
to Infection
(negative)
o

China
o
Consortium of
Chest
CT
Image
o
Investigation
(CC-CCII)
o
Dataset
o
o

COVID-CTset

MosMedData

o

o

Sun Yat-sen Memorial
Hospital and Third Affiliated
Hospital of Sun Yat-sen 929
University,
Guangzhou,
China
The first Affiliated Hospital
of Anhui Medical University,
Anhui, China
964
West
China
Hospital,
Sichuan, China
Nanjing Renmin Hospital,
Nanjing, China
Yichang Central Peopleâ€™s
Hospital, Hubei, China
849
Renmin Hospital of Wuhan
University, Wuhan, China

Negin Medical Center, Sari,
Iran

Municipal
hospitals
Moscow, Russia

in

1544

COVID-19
positive

1556

Common
Pneumonia
(negative)

1078

Normal
Lung
(negative)

95

281

282

1068

254

254

COVID-19
positive
Normal
lung
(negative)
CT-0 â€“ not
consistent
with
pneumonia
(can
include
both
COVID-19
positive

http://ncovai.big.ac.cn
/download

https://githu
b.com/mr7
495/COVID
-CTset

https://mos
med.ai/

UTSW dataset is non-public. In accordance with HIPAA policy, access to the dataset will be granted on a case by
case basis upon submission of a request to the corresponding authors and the institution.
1

684

684

125

125

45

45

2

2

and
negative)
CT-1 â€“ Mild
(COVID-19
positive)
CT-2
â€“
Moderate
(COVID-19
positive)
CT-3
â€“
Severe
(COVID-19
positive)
CT-4
â€“
Critical
(COVID-19
positive)

II.2. Model Architecture

Figure 2: Schematic of deep learning architecture used in the study. Black numbers
represent the feature shape of each layer prior to the flattening operation. Red numbers
represent the number of features at each layer.
The model used in this study was a classification style convolutional neural network (CNN)
model28-31, with specifics shown in Figure 2. The input shape was set to 512 x 512 x 128. In total,
there are 5 resolution levels of convolutions and 4 downsampling operations prior to the flattening
operation. The downsampling size also varied each time, and was set as (4,4,4), (4,4,2), (4,4,2),
and (2,2,2), respectively. In total, this converts the data shape from 512 x 512 x 128 to 4 x 4 x 4.
At each resolution level, a series of operations consisting of Convolution, Rectified Linear Unit
activation (ReLU), Group Normalization32, and DropBlock33 is applied twice, consecutively. The
convolution kernel size varied at each resolution level: (3,3,3), (5,5,5), (5,5,3), (5,5,3), and (3,3,3),
respectively. The number of filters, indicated by the red numbers in Figure 2, at each convolution
started at eight, and doubled after each downsampling operation. After these operations, the
feature data are flattened into a single vector of length 8192. Then, a series of operations
consisting of fully connected calculations, ReLU, Group Normalization, and Dropout34 follows.
This is performed at total of four times, calculating 1024 features each time. Then, one more full
connection is applied to reduce the data into two outputs, and a softmax operation is applied.

III.3. Training and Data Augmentation
In total, nine models were trained in this study using the training and validation data outlined in
Section III.1. and were split into two categories: 1) single dataset training and 2) multiple dataset
training. We trained three models on a single dataset, one each on the UTSW, CC-CCII, and the
COVID-CTset datasets. No model was trained on the MosMedData by itself, since this dataset
does not have any negative labels. For multiple-dataset training, we trained 6 models with
different combinations of datasets: 1) UTSW + CC-CCII, 2) UTSW + COVID-CTset, 3) CC-CCII
+ COVID-CTset, 4) UTSW + CC-CCII + COVID-CTset, 5) CC-CCII + COVID-CTset +
MosMedData, and 6) UTSW + CC-CCII + COVID-CTset + MosMedData.
Some additional operations were applied to format and augment the CT data for model training.
For CT data with less than 128 slices, slices of zeros were padded onto the CT slices until the
total data volume had 128 slices. The number of slices superior and inferior to the CT data was
uniformly and randomly decided at each iteration. For data with more than 128 slices, a random
continuous volume of 128 slices was selected. The data were then normalized in one of two ways:
1) from 0 to 1, or 2) from 0 to

ğ‘šğ‘šğ‘šğ‘šğ‘šğ‘š(ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘ğ‘‘)
2ğ‘›ğ‘›

, where ğ‘›ğ‘› is the smallest integer possible while keeping 2ğ‘›ğ‘›

larger than the maximum value in the CT volume. The normalization method was randomly
chosen with a 50% chance during each training iteration. An additional step was applied to decide,
at a 50% chance, whether this data would be fed into the model for training, or if additional data
augmentation would be applied. If yes to additional data augmentation, then the function randomly
flipped, transposed, rotated, or scaled the data. For the flip augmentation, there was a 50%
chance it would individually apply a flip to each axis (row, column, slice). For the transpose
augmentation, there was a 50% chance it would transpose the row and column of the data (no
transpose operation was ever applied using the slice dimension). For the rotate augmentation, a
random integer, {0,1,2,3}, was generated and multiplied against 90Â° to determine the rotation
angle, then applied only on the row and column dimensions. For the scale augmentation, there
was a 50% chance that a scaling factor was applied, and the scale was a uniform random number
from 0 to 1.
Each model trained for a total of 250000 iterations, using the Adam optimizer35 with a learning
rate of 1 Ã— 10âˆ’5 . To prevent overfitting on the training data, the accuracy was evaluated on the
validation data every 500 iterations, and the instance of the model with the highest validation
accuracy was saved as the final model for evaluation. The models were trained using NVIDIA
V100 GPUs with 24 GB of memory.

III.4. Evaluation
All nine of the trained models were evaluated on the test data of each dataset. For volumes with
less than 128 slices, zero padding on the slices was evenly applied in the superior and inferior
directions, to keep the data centered. For volumes greater than 128 slices, a sliding window
technique was applied across the volume and the model made multiple predictions. The number
of slices in a patch was 128 and the stride size was 32 slices. The prediction with the highest
COVID-19 probability was taken as the modelâ€™s final prediction.
A threshold was selected based on maximizing the prediction accuracy on the validation data and
applied to the testing set. In the cases where the â€œoptimalâ€ threshold was a trivial value (e.g.,
threshold = 0 for the MosMedData, which only has positive labels), we took the argmax of the
output as the prediction instead. The true positives (ğ‘‡ğ‘‡ğ‘‡ğ‘‡), true negatives (ğ‘‡ğ‘‡ğ‘‡ğ‘‡), false positives (ğ¹ğ¹ğ¹ğ¹),

and false negatives (ğ¹ğ¹ğ¹ğ¹) were counted, and a normalized confusion matrix is generated for each
dataset. Averaged confusion matrices were calculated with and without the MosMedData. An
evenly weighted average was chosen.
Receiver operating characteristic (ROC) curves were calculated on the test data by varying the
positive predictive threshold from 0 to 1, at 0.01 intervals. The area under the curve (AUC) was
calculated to determine the overall performance of each model on each dataset. The
MosMedData was excluded from the ROC and AUC analysis, since it is missing negative labels.

III. Results
Each model took about five days on average to train on a GPU. In total, for nine models, this is
equivalent to 45 GPU-days of training. Each model prediction takes an average of 0.53 seconds,
which makes it very useful for near real-time application.

Figure 3: Confusion matrices on the test data for each of the models trained on a single
dataset. Each row represents the datasets that the model was trained on, and each column
represents the datasets that the model was evaluated on. Note that MosMedData does not
have any negative label data. The labeling threshold used for each model is indicated on
the lower left of each confusion matrix (ğ’•ğ’• = #); this threshold was fine-tuned from the
validation data to maximize the trace of the confusion matrix for each respective category.
ğ’•ğ’• = ğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µ indicates that the argmax of the model output was used to determine whether
the prediction was positive or negative.
The single dataset modelsâ€™ predictive accuracy ï¿½

ğ‘‡ğ‘‡ğ‘‡ğ‘‡+ğ‘‡ğ‘‡ğ‘‡ğ‘‡

ğ‘‡ğ‘‡ğ‘‡ğ‘‡+ğ‘‡ğ‘‡ğ‘‡ğ‘‡+ğ¹ğ¹ğ¹ğ¹+ğ¹ğ¹ğ¹ğ¹

ï¿½ on the test dataset is displayed in

Figure 3. Overall, each model performed best on the dataset that it trained on, with an accuracy
as high as 0.97 for the CC-CCII model evaluated on the CC-CCII data. The model that performed
the worst on its own dataset was COVID-CTset, with an accuracy of 0.86. The UTSW model had
an accuracy of 0.87 on its own dataset. Since the test data were held out of the training and
validation phase, it is a strong indicator that the model did not overfit to its specific training data.
However, the models performed much more poorly when evaluated on a dataset they had not

seen before, which signifies that the model did not generalize well to the new dataset type. The
worst performance was the CC-CCII model evaluated on the UTSW dataset, which had an
accuracy of 0.47. All three models had poor performance on the MosMedData dataset and
classified the majority of the patient cases as negative.

Figure 4: Confusion matrices on the test data for each of the models trained on multiple
datasets. Each row represents the datasets that the model was trained on, and each
column represents the datasets that the model was evaluated on. The labeling threshold
used for each model is indicated on the lower left of each confusion matrix (ğ’•ğ’• = #). ğ’•ğ’• =
ğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µğ‘µ indicates that the argmax of the model output was used to determine whether the
prediction was positive or negative.
Figure 4 shows the confusion matrices of the performance of models trained on multiple datasets
against the test data. The multiple dataset model that had the best accuracy when evaluated on
the UTSW test set was the UTSW + CC-CCII model, with 0.93 accuracy. When evaluating on the
CC-CCII test set, there was a tie for best accuracy 0.96 between the UTSW + CC-CCII + COVIDCTset and the UTSW + CC-CCII models. When evaluating on the COVID-CTset, the UTSW +
COVID-CTset performed best, with a 0.94 accuracy. The best multiple-dataset models
outperformed their single-dataset counterparts with regards to accuracy. However, these models

still had poor accuracy when evaluated on a test dataset they have not seen before. For example,
the model trained with the UTSW and COVID-CTset together had improved accuracies to 0.91
and 0.94 when evaluated on the test sets of the UTSW and COVID-CTset datasets, respectively.
However, when evaluated on the CC-CCII dataset, the accuracy was 0.57. Including the
MosMedData in the model training improved the total average performance but did not improve
the performance when evaluating models on the individual UTSW, CC-CCII, and COVID-CTset
datasets.

Figure 5: ROC curves on the test data for the models trained on single datasets. Each row
represents the datasets that the model was trained on, and each column represents the
datasets that the model was evaluated on.
Figure 5 shows the ROC curves of the single-dataset models. The models, when evaluated on
the same dataset that they trained on, showed good AUCs of 0.826 (UTSW), 0.988 (CC-CCII),
and 0.873 (COVID-CTset). The models performed considerably worse when evaluated on
different datasets, with AUCs ranging from 0.405 to 0.570, which is close to just random guessing
(i.e., AUC=0.5). The ROC curves of the multiple-dataset models are shown in Figure 6. For each
datasetâ€”UTSW, CC-CCII, and COVID-CTsetâ€”the best performing models were the UTSW +
COVID-CTset (AUC = 0.937), the UTSW + CC-CCII + COVID-CTset (AUC = 0.989), and the
UTSW + COVID-CTset (AUC = 0.926) models, respectively. Since the test data were held entirely
separate from the model development process, and used only for evaluation, this shows once
again that the models did not overfit to their own training data. Similar to the single-dataset models,

the multiple-dataset models also performed poorly when predicting on datasets they had never
seen before, with AUCs ranging from 0.380 to 0.540.

Figure 6: ROC Curves on the test data for the models that trained on multiple datasets.
Each row represents the datasets that the model was trained on, and each column
represents the datasets that the model was evaluated on.

IV. Discussion
In this study we demonstrate that our DL models can correctly identify patients that are COVID19â€“positive with high accuracy, but only when the model was trained on the same datasets that
it was tested on. Otherwise, the performance is poorâ€”close to random guessingâ€”which indicates
that the model cannot easily generalize to an entirely new dataset distribution that it has never
seen before for COVID-19 classification. Several data augmentation techniques were applied
during training to prevent overfitting on the test set. In addition, the weights of the model that
performed the best on the validation data with regards to accuracy were used as the final model.
Dropout and DropBlock regularization were added to further prevent the model from overfitting.
We additionally observed that certain combined dataset models performed best for particular
datasets in detecting patients who are positive for COVID-19. For example, we found that the
highest performing model in the dataset from UTSW dataset was obtained when the training step
combined UTSW and COVID-CTset datasets. This may have occurred due to the relatively low
sample count in the UTSW dataset (73 positive, 170 negative patients for training); therefore,
adding data samples from COVID-CTset improved with DL-modelâ€™s AUC from 0.826 to 0.937 on
the UTSW dataset. However, adding more data from different distributions into the training did
not always monotonically improve the model's performance. For example, adding the CC-CCII
data for training did not improve the model performance, with the AUC of 0.920 for the UTSW
dataset. Adding MosMedData into the training lowered the performance of the model on the other
three datasets. This is likely because the original intent of MosMedData was to train a model to
categorize the severity of COVID-19 into five classes and, therefore lacked negative labels.
Without definitive negative labels, our models likely learned simply to identify the data source as
MosMedData and compromised some of their learning capacity and performance to use the
relevant imaging features for the predictions. This does serve as an important lesson in data
collection: datasets from a particular healthcare center or region should be fully representative of
the task at hand to be used in training. Simply collecting COVID-19â€“positive patients from one
source and negative patients from a different source is likely to introduce an uncorrectable bias
during training that led to poor model performance.
Although this study did not fully explore possible techniques to improve robustness and prevent
overfitting, it may serve as a baseline for future model generalization studies that use medical
data for the clinical implementation of COVID-19â€“related classification models. We will continue
to explore the limits of model generalization with respect to improving the algorithm and to the
intra- and inter-source data variability, regarding the identification of COVID-19â€“positive patients
by their medical data. As a whole, the deep learning models achieved high performance on the
unseen test set from the same distribution that they were trained on, which indicates that we did
not have typical overfitting problem with the training data. The low performance on datasets that
the models had never seen before may actually be an indicator that the problem is not in the
approach to initial algorithm developmentâ€”the problem may be the transfer and deployment of
the algorithm to a new clinical setting. Creating a globally generalizable algorithm is a tall order
when people around the world have vastly different demographics and data collection protocols.
With limited data and learning time, these AI algorithms are bound to fail when they encounter a
unique data distribution they have never seen before. This results underscore the limited
versatility of AI algorithms which may hamper widespread adoption of AI algorithms for automated

diagnosis of radiology images. This is in contrast to radiologists who in general can easily adapt
to new clinical practices quickly. Perhaps we need to recalibrate our mindset in regards to the
expectation for these AI algorithmsâ€”we should expect that these AI algorithms will always need
to be fine-tuned to the local distribution when implemented and deployed in a specific clinical
setting, then need to be retuned over time as distributions inevitably shift, either through
demographic shifts or the advancement of new treatment technologies. Transfer learning and
continuous learning techniques36 are an active field of research, and may become critical
components to rapidly transferring, deploying, and maintaining an AI model into the clinic.
AI tools designed for automatic identification of diseases on CT datasets, such as COVID-19, will
only succeed if they can prove their robustness against a wide array of patient populations, scan
protocols, and image quality. Notwithstanding, they hold the promise of becoming a powerful
resource for identifying diseases where time to detection is a critical variable. In the case of
COVID-19, it is well known that many infections are asymptomatic, of which up to 54% will present
abnormalities on chest CT37. Thus, COVID-19 can be incidentally found on routine imaging.
Timely identification of incidental cases of COVID-19 on chest CT by AI tools could lead to
adequate prioritization of scans for reporting, resulting in prompt initiation of disease tracking and
control measures. Moreover, the model architecture developed in this work can also serve as a
template for similar tools tailored for detecting other clinical conditions.

V. Conclusion
The deep learning models were capable of identifying COVID-19â€“positive patients when the
testing data was in the same dataset as the training data, whether the model was trained on a
single dataset or on multiple datasets. However, we found poor performance, close to random
guessing, when models were evaluated on datasets that they had never seen. This is likely due
to different factors, such as patient demographics, image acquisition methods/protocols, or
diagnostic methods, causing a data shift between different countriesâ€™ data. This lack of
generalization for the identification of COVID-19â€“positive patients may not necessarily mean that
the models were trained poorly, but rather the distribution of the training data may be too different
from the evaluation data. Transfer learning and continuous learning may become imperative tools
for tuning and deploying a model in a new clinical setting.

Acknowledgements
We would like to thank Jonathan Feinberg for editing the manuscript.

Dataset and Code Availability
UTSW dataset is non-public. In accordance with HIPAA policy, access to the dataset will be
granted on a case-by-case basis upon submission of a request to the corresponding authors
and the institution.
The DL models and related code developed in this study are available upon request for noncommercial research purposes.

References
1
2
3
4
5
6

7
8

9

10

11
12
13
14

15
16
17
18

19
20
21
22
23

PÃ©rez-PeÃ±a,
R.
Virus
Has
Killed
1
Million
Worldwide,
<https://www.nytimes.com/live/2020/09/28/world/covid-19-coronavirus> (2020).
Guan, W.-j. et al. Clinical characteristics of coronavirus disease 2019 in China. New
England journal of medicine 382, 1708-1720 (2020).
McCullough, P. A. et al. Pathophysiological basis and rationale for early outpatient
treatment of SARS-CoV-2 (COVID-19) infection. The American journal of medicine (2020).
McCullough, P. A. et al. Multifaceted highly targeted sequential multidrug treatment of
early ambulatory high-risk SARS-CoV-2 infection (COVID-19). (2020).
FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals (FLARE),
<https://clinicaltrials.gov/ct2/show/NCT04499677> (2020).
Wang, L., Lin, Z. Q. & Wong, A. Covid-net: A tailored deep convolutional neural network
design for detection of covid-19 cases from chest x-ray images. Scientific Reports 10, 112 (2020).
Sethy, P. K. & Behera, S. K. Detection of coronavirus disease (covid-19) based on deep
features. Preprints 2020030300, 2020 (2020).
Narin, A., Kaya, C. & Pamuk, Z. Automatic detection of coronavirus disease (covid-19)
using x-ray images and deep convolutional neural networks. arXiv preprint
arXiv:2003.10849 (2020).
Apostolopoulos, I. D. & Mpesiana, T. A. Covid-19: automatic detection from x-ray images
utilizing transfer learning with convolutional neural networks. Physical and Engineering
Sciences in Medicine, 1 (2020).
Hemdan, E. E.-D., Shouman, M. A. & Karar, M. E. Covidx-net: A framework of deep
learning classifiers to diagnose covid-19 in x-ray images. arXiv preprint arXiv:2003.11055
(2020).
Wang, S. et al. A deep learning algorithm using CT images to screen for Corona Virus
Disease (COVID-19). MedRxiv (2020).
Xu, X. et al. Deep learning system to screen coronavirus disease 2019 pneumonia. arXiv
2020. arXiv preprint arXiv:2002.09334.
Ozturk, T. et al. Automated detection of COVID-19 cases using deep neural networks with
X-ray images. Computers in Biology and Medicine, 103792 (2020).
Shibly, K. H., Dey, S. K., Islam, M. T. U. & Rahman, M. M. COVID Faster R-CNN: A Novel
Framework to Diagnose Novel Coronavirus Disease (COVID-19) in X-Ray Images.
medRxiv (2020).
Oh, Y., Park, S. & Ye, J. C. Deep learning covid-19 features on cxr using limited training
data sets. IEEE Transactions on Medical Imaging 39, 2688-2700 (2020).
Jin, C. et al. Development and evaluation of an artificial intelligence system for COVID-19
diagnosis. Nature communications 11, 1-14 (2020).
Topol, E. J. Is my cough COVID-19? The Lancet 396, 1874 (2020).
Barish, M., Bolourani, S., Lau, L. F., Shah, S. & Zanos, T. P. External validation
demonstrates limited clinical utility of the interpretable mortality prediction model for
patients with COVID-19. Nature Machine Intelligence, 1-3 (2020).
Yan, L. et al. An interpretable mortality prediction model for COVID-19 patients. Nature
Machine Intelligence, 1-6 (2020).
Quanjel, M. J. et al. Replication of a mortality prediction model in Dutch patients with
COVID-19. Nature Machine Intelligence, 1-2 (2020).
Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19: systematic
review and critical appraisal. bmj 369 (2020).
Laghi, A. Cautions about radiologic diagnosis of COVID-19 infection driven by artificial
intelligence. The Lancet Digital Health 2, e225 (2020).
Bachtiger, P., Peters, N. S. & Walsh, S. L. Machine learning for COVID-19â€”asking the
right questions. The Lancet Digital Health 2, e391-e392 (2020).

24
25

26

27
28
29
30
31
32
33
34

35
36
37

NaudÃ©, W. Artificial intelligence vs COVID-19: limitations, constraints and pitfalls. AI &
society 35, 761-765 (2020).
Zhang, K. et al. Clinically applicable AI system for accurate diagnosis, quantitative
measurements, and prognosis of covid-19 pneumonia using computed tomography. Cell
(2020).
Rahimzadeh, M., Attar, A. & Sakhaei, S. M. A Fully Automated Deep Learning-based
Network For Detecting COVID-19 from a New And Large Lung CT Scan Dataset. medRxiv
(2020).
Morozov, S. et al. MosMedData: Chest CT Scans With COVID-19 Related Findings
Dataset. arXiv preprint arXiv:2005.06465 (2020).
LeCun, Y. et al. Backpropagation applied to handwritten zip code recognition. Neural
computation 1, 541-551 (1989).
LeCun, Y. & Bengio, Y. Convolutional networks for images, speech, and time series. The
handbook of brain theory and neural networks 3361, 1995 (1995).
LeCun, Y., Bottou, L., Bengio, Y. & Haffner, P. Gradient-based learning applied to
document recognition. Proceedings of the IEEE 86, 2278-2324 (1998).
LeCun, Y., Haffner, P., Bottou, L. & Bengio, Y. in Shape, contour and grouping in computer
vision 319-345 (Springer, 1999).
Wu, Y. & He, K. in Proceedings of the European Conference on Computer Vision (ECCV).
3-19.
Ghiasi, G., Lin, T.-Y. & Le, Q. V. in Advances in Neural Information Processing Systems.
10727-10737.
Srivastava, N., Hinton, G. E., Krizhevsky, A., Sutskever, I. & Salakhutdinov, R. Dropout: a
simple way to prevent neural networks from overfitting. Journal of machine learning
research 15, 1929-1958 (2014).
Kingma, D. & Ba, J. Adam: A method for stochastic optimization. arXiv preprint
arXiv:1412.6980 (2014).
Torrey, L. & Shavlik, J. in Handbook of research on machine learning applications and
trends: algorithms, methods, and techniques 242-264 (IGI global, 2010).
Inui, S. et al. Chest CT findings in cases from the cruise ship diamond princess with
Coronavirus disease (COVID-19). Radiology: Cardiothoracic Imaging 2, e200110 (2020).

